MR spectroscopy in the evaluation of recurrent contrast-enhancing lesions in the posterior fossa after tumor treatment

Neuroradiology

Volumn 46, Issue 7, 2004, Pages 541-549

  Weybright, P ^a   Maly, P ^a   Gomez Hassan, D ^a   Blaesing, C ^a   Sundgren, P C ^a  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

2D CSI; Brain; MRS; Posterior fossa; Radiation necrosis; Tumor

Indexed keywords

ANTINEOPLASTIC AGENT; CHOLINE; CREATINE; GADOLINIUM PENTETATE; N ACETYLASPARTIC ACID;

ADOLESCENT; ADULT; ARTICLE; BRAIN RADIATION; BRAIN STEM TUMOR; CHILD; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC VALUE; EVALUATION; FEASIBILITY STUDY; FEMALE; HUMAN; MALE; MINIMAL RESIDUAL DISEASE; NEUROSURGERY; POSTERIOR CRANIAL FOSSA TUMOR; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TUMOR RECURRENCE; WHITE MATTER;

EID: 4344621458     PISSN: 00283940     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00234-004-1195-1     Document Type: Article

References (22)

1. Bonavita S, Di Salle F, Tedeschi G (1999) Proton MRS in neurological disorders. Eur Radiol 30:125-131
2. Fulham MJ, Bizzi A, Dieta MJ, Shih HH, Raman R, Sobering GS, Frank JA, Dwyer AJ, Alger JR, Di Chiro G (1992) Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology 185:675-686
3. Rock JP, Hearshen D, Scarpace L, Croteau D, Gutierrez J, Fisher JL, Rossenblum ML, Mikkelsen T (2002) Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis. Neurosurgery 51:912-919
4. Croteau D, Scarpace L, Hearschen D, Gutierrez J, Fischer J, Rock JP, Mikkelsen T (2001) Correlation between magnetic resonance spectroscopy imaging and image-guided biopsies: semiquantitative and qualitative histopathological analyses of patients with untreated glioma. Neurosurgery 49:823-829
5. Dowling C, Bollen AW, Noworolski SM, McDermott MW, Barbaro NM, Day MR, Henry RG, Chang SM, Dillon WP, Nelson SJ, Vigneron DB (2001) Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. AJNR Am J Neuroradiol 22:604-612
6. Schlemmer JP, Bachert P, Henze M, Buslei R. Herfarth KK, Debus J, van Kaick G (2002) Differentiation of radiation necrosis from tumor progression using proton magnetic resonance spectroscopy. Neuroradiology 44:216-222
7. Chong VF, Rumpel H, Fan YF, Mukherji SK (2001) Temporal lobe changes following radiation therapy: imaging and proton MR spectroscopic findings. Eur Radiol 11:317-324
8. Chong VF, Rumpel H, Aw YS, Ho GL, Fan YF, Chua EJ (1999) Temporal lobe necrosis following radiation therapy for nasopharyngeal carcinoma: 1H MR spectroscopic findings. Int J Radiat Oncol Biol Phys 45:699-705
9. Hall WA, Martin A, Liu H, Truwit CL (2001) Improving diagnostic yield in brain biopsy: coupling spectroscopic targeting with real-time needle placement. J Magn Reson Imaging 13:12-15
10. Nafe R, Herminghaus S, Raab P, Wagner S, Pilatus U, Schneider B, Schon W, Zanella F, Lanfermann H (2003) Preoperative proton-MR spectroscopy of gliomas - correlation with quantitative nuclear morphology in surgical specimen. J Neurooncol 63:233-245
11. Moller-Hartmann W, Herminghaus S, Krings T, Marquardt G, Lanfermann H, Pilatus U, Zanella FE (2002) Clinical application of proton magnetic resonance spectroscopy to the diagnosis of intracranial mass lesions. Neuroradiology 44:371-381
12. Norfray JF, Tomita T, Byrd SE, Ross BD, Berger PA, Miller RS (1999) Clinical impact of MR spectroscopy when MR imaging is indeterminate in pediatric brain tumors. AJR Am J Roentgenology 173:119-125
13. Lin A, Bluml S, Mamelak AN (1999) Efficacy of proton magnetic resonance spectroscopy in clinical decision making for patients with suspected malignant brain tumors. J Neurooncol 45:69-81
14. Bendszus M, Warmuth-Metz M, Klein R, Burger R, Schichor J, Tonn JC, Solymosi L (2000) MR spectroscopy in gliomatosis cerebri. AJNR Am J Neuroradiol 21:375-380
15. Galanaud D, Le Fur Y, Nicoli F, Denis B, Confort-Gouny S, Ranjeva J-P, Viout P, Pelletier J, Cozzone P (2001) Regional metabolite levels of the normal posterior fossa studied by proton chemical shift imaging. MAGMA 13:127-133
16. Tedeschi G, Litvan I, Bonavita S, Bertolino A, Lundbom N, Patronas NJ, Hallett M (1997) Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease, and corticobasal degeneration. Brain 120:1541-1552
17. Mascalchi M, Tosetti M, Plasmati R, Bianchi MC, Tessa C, Salvi F (1998) Proton magnetic resonance spectroscopy in an Italian family with spinocerebellar ataxia type I. Ann Neurol 43:244-252
18. Martin PR, Gibbs SJ, Nimmerrichter AA, Riddle WR, Welch LW, Willcott MR (1995) Brain proton magnetic resonance spectroscopy studies in recently abstinent alcoholics. Alcohol Clin Exp Res 19:1078-1082
19. Blaesing CM, Rohrer SE, Gomez-Hassan D, Maly Sundgren P (2003) Challenging voxel placement for brain MR spectroscopy. SMRT 12th Annual Meeting, Syllabus p 308
20. Mascalchi M, Brugnoli R, Guerrini L, Belli G, Nistri M, Politi LS, Gavazzi C, Lolli F Argenti G, Villari N (2002) Single-voxel long TE 1H-MR spectroscopy of the normal brainstem and cerebellum. J Magn Reson Imaging 16:532-537
21. Rutkoski T, Tarnawski R, Sokol M, Maciejewski B (2003) Proton-MR spectroscopy of normal brain tissue before and after postoperative radiotherapy because of primary brain tumors. Int J Radiat Oncol Biol Phys 56:1381-1389
22. Isobe T, Matsumara A, Anno I, Nagatomo Y, Yoshizawa T, Itai Y (2003) Changes in proton-MRS in glioma patients before and after irradiation and the significance of quantitative analysis of choline-containing compounds. No Shinkei Geka 31:167-172